Inventor
SIT SING-YUEN
US58 patents
⚠️ This page may combine multiple inventors who share the name “SIT SING-YUEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
29 patentsUS7449479B2Nov 11, 2008
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO67 citations99
US6995174B2Feb 7, 2006
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO194 citations98
US7915291B2Mar 29, 2011
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO40 citations96
US6001836ADec 14, 1999
Dihydropyridine NPY antagonists: cyanoguanidine derivatives
BRISTOL MYERS SQUIBB CO98 citations95
US6562846B2May 13, 2003
Bisarylimidazolyl fatty acid amide hydrolase inhibitors
BRISTOL MYERS SQUIBB CO17 citations93
US5922735AJul 13, 1999
4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
BRISTOL MYERS SQUIBB CO22 citations93
US5892045AApr 6, 1999
4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
BRISTOL MYERS SQUIBB CO19 citations93
US8710229B2Apr 29, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO10 citations92
US9227940B2Jan 5, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US8906889B2Dec 9, 2014
C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
BRISTOL MYERS SQUIBB CO12 citations84
US7772180B2Aug 10, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO17 citations84
US6444675B2Sep 3, 2002
4-alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists
BRISTOL MYERS SQUIBB CO14 citations84
US6432960B2Aug 13, 2002
Squarate derivatives of dihydropyridine NPY antagonists
BRISTOL MYERS SQUIBB CO15 citations84
US10913738B2Feb 9, 2021
Aminotriazolopyridines as kinase inhibitors
BRISTOL MYERS SQUIBB CO7 citations83
US8889871B2Nov 18, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO3 citations74
US6391881B2May 21, 2002
Thiourea derivatives of dihydropyridine NPY antagonists
BRISTOL MYERS SQUIBB CO13 citations74
US6949574B2Sep 27, 2005
(Oxime)carbamoyl fatty acid amide hydrolase inhibitors
BRISTOL MYERS SQUIBB CO9 citations73
US6177429B1Jan 23, 2001
Dihydropyrazine derivatives as NPY antagonists
BRISTOL MYERS SQUIBB CO7 citations73
US9636375B2May 2, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO1 citations63
US7049309B2May 23, 2006
3-Thia-4-arylquinolin-2-one potassium channel modulators
BRISTOL MYERS SQUIBB CO3 citations63
US12157733B2Dec 3, 2024
Aminotriazolopyridines as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US6479482B2Nov 12, 2002
Alkylamine derivatives of dihydropyridine NPY antagonists
BRISTOL MYERS SQUIBB CO2 citations62
US5321046AJun 14, 1994
Hypocholesterolemic unsymmetrical dithiol ketals
BRISTOL MYERS SQUIBB CO2 citations57
US12275721B2Apr 15, 2025
Indazole carboxamides as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US12172975B2Dec 24, 2024
1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)
BRISTOL MYERS SQUIBB CO0 citations52
US8889854B2Nov 18, 2014
C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
BRISTOL MYERS SQUIBB CO1 citations52
USRE39634EMay 15, 2007
Bisarylimidazoly fatty acid amide hydrolase inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US7179920B2Feb 20, 2007
3-thia-4-arylquinolin-2-one derivatives
BRISTOL MYERS SQUIBB CO0 citations52
US7151180B2Dec 19, 2006
Potassium channel modulators
BRISTOL MYERS SQUIBB CO0 citations52
BRISTOL MYERS CO
10 patentsUS4897490AJan 30, 1990
Antihypercholesterolemic tetrazole compounds
BRISTOL MYERS CO27 citations93
US5110940AMay 5, 1992
Antihypercholesterolemic tetrazole compounds
BRISTOL MYERS CO15 citations74
US4870187ASep 26, 1989
Antihypercholesterolemic tetrazol-1-yl compounds
BRISTOL MYERS CO7 citations74
US4898949AFeb 6, 1990
Intermediates for the preparation of antihypercholesterolemic tetrazole compounds
BRISTOL MYERS CO7 citations73
US5070206ADec 3, 1991
Tetrazol-1-yl containing intermediates
BRISTOL MYERS CO0 citations52
US5068346ANov 26, 1991
Tetrazole compounds
BRISTOL MYERS CO0 citations52
US5028730AJul 2, 1991
Antihypercholesterolemic nitrile compounds
BRISTOL MYERS CO1 citations52
US5010205AApr 23, 1991
Antihypercholesterolemic tetrazol-1-yl intermediates
BRISTOL MYERS CO0 citations52
US4981991AJan 1, 1991
Antihypercholesterolemic nitrile compounds
BRISTOL MYERS CO0 citations52
US4939265AJul 3, 1990
Intermediates and process for the preparation of antihypercholesterolemic tetrazole compounds
BRISTOL MYERS CO0 citations52
REGUEIRO-REN ALICIA
4 patentsUS8846647B2Sep 30, 2014
C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activity
REGUEIRO-REN ALICIA19 citations83
US8802661B2Aug 12, 2014
C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitors
REGUEIRO-REN ALICIA14 citations83
US8754068B2Jun 17, 2014
Modified C-3 betulinic acid derivatives as HIV maturation inhibitors
REGUEIRO-REN ALICIA15 citations83
US8748415B2Jun 10, 2014
C-28 amines of C-3 modified betulinic acid derivatives as HIV maturation inhibitors
REGUEIRO-REN ALICIA16 citations83
VIIV HEALTHCARE UK NO 5 LTD
3 patentsUS11084845B2Aug 10, 2021
C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
VIIV HEALTHCARE UK NO 5 LTD1 citations62
US10421774B2Sep 24, 2019
C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
VIIV HEALTHCARE UK NO 5 LTD1 citations62
US9914747B2Mar 13, 2018
Extended betulinic acid analogs
VIIV HEALTHCARE UK NO 5 LTD0 citations52
WANG ALAN XIANGDONG
1 patentVIIV HEALTHCARE UK (NO 4) LTD
1 patentVIIV HEALTHCARE UK NO 4 LTD
1 patentPURDUE RESEARCH FOUNDATION
1 patentShowing the top 50 of 58 patents by PatentIndex Score.